Today, we are pleased to announce Dr. @VivekSubbiah, a globally recognized key opinion leader in precision medicine and early-phase research, will be joining the SCRI team. Learn more about his new role and contributions to drug development:
Sarah Cannon Docs
@SarahCannonDocs
A leading oncology research organization conducting community-based clinical trials.
